Gemtuzumab in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00022321 · UNKNOWN

Trial details

NCT number: NCT00022321
Sponsor: Jonsson Comprehensive Cancer Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2001-09-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.